What FTC Health Claims Substantiation Actually Requires

What does competent and reliable scientific evidence mean?

The FTC's Health Products Compliance Guidance, issued in December 2022 to replace its 1998 dietary supplement advertising guide, defines the standard precisely. Evidence must consist of tests, analyses, research, or studies that were conducted and evaluated objectively by experts in the relevant disease, condition, or function, and that are generally accepted in the profession to yield accurate and reliable results.

The research must also be sufficient in quality and quantity, judged against standards accepted in the relevant scientific field and weighed against the entire body of relevant evidence. A single favorable study does not settle the question if the broader literature cuts the other way.

For health benefit claims, the guidance states that substantiation will generally need to be randomized, controlled human clinical testing. There is no fixed number of required trials, but independent replication adds weight, and the FTC evaluates parameters such as sample size, duration, and outcome measures.

Which types of evidence do not count

The guidance is explicit about what fails the standard on its own. Quality matters more than quantity: a stack of flawed studies does not add up to substantiation.

It also matters whether the study tested what you are selling. The guidance flags research that used a different formulation or a higher concentration than the marketed product as inadequate support.

• Anecdotal evidence, including consumer surveys and testimonials, is never sufficient, even when the experiences are genuine, because results may reflect placebo effects.
• A healthcare practitioner's clinical observations are treated as anecdotal, not as evidence of causation.
• Animal and in vitro studies can provide background support but cannot substantiate human benefit claims without human RCT confirmation.
• Public health recommendations and medical organization advisories are not substantiation for product claims.

How the FTC enforces the standard

Since 1998 the FTC has settled or adjudicated more than 200 cases involving false or misleading claims about the benefits or safety of supplements, foods, OTC drugs, homeopathic products, and other health products. Remedies range from mandated disclosures and corrective advertising to marketing bans, consumer refunds, and civil penalties.

On April 13, 2023, the agency sent Notices of Penalty Offenses to approximately 670 companies marketing OTC drugs, homeopathic products, dietary supplements, or functional foods. Recipients face civil penalties of up to $50,120 per violation if they make claims the FTC has already found unlawful in prior administrative cases.

The notices cover five practices: lacking a reasonable basis for objective claims, lacking competent and reliable scientific evidence for health or safety claims, lacking at least one well-controlled human clinical trial for serious disease claims, misrepresenting the level of substantiation, and falsely claiming something is scientifically proven.

Implied claims count as much as express ones

The FTC judges an ad by its net impression, meaning the whole ad taken together: text, product name, charts, and images. If an ad supports more than one reasonable interpretation, the advertiser must substantiate each one.

This is where wellness marketing most often slips. A page never states that a service treats a condition, but the before-and-after imagery, the condition-specific keywords, and the patient story combine to imply it. The FTC also reads claims from the standpoint of the intended audience, so copy aimed at people with a specific condition is held to what that audience would take away.

A claim-review workflow for a wellness practice

A repeatable review process costs less than one demand letter. Run every service page, ad, email, and social post through the same gate before it publishes.

The goal is not to strip your marketing of substance. It is to make sure every stated and implied promise traces to evidence you could hand a regulator, and to rewrite or cut the ones that do not.

• Inventory every express claim, then list what each ad implies as a whole, including images and testimonials.
• For each claim, identify the specific studies behind it and confirm they tested the same intervention, dosage or protocol, and population you market to.
• Check study quality: randomized, controlled, human, statistically significant between-group results, and consistent with the broader literature.
• Remove or rewrite anything resting only on testimonials, practitioner observation, traditional use, or animal and in vitro data.
• Document the substantiation file before publication, since the reasonable basis must exist when the claim is first made.
• Re-review quarterly and whenever new research on your interventions appears.

Where this fits in a growth program

Compliance and growth are not in tension. Claims that survive this review tend to be specific, verifiable, and more persuasive to patients than inflated ones, and they keep your booking pipeline out of enforcement risk.

If marketing review is competing with patient care for your hours, a partner that builds substantiation checks into content production removes the tradeoff. That is how Rank & Rejuvenate approaches wellness marketing: claims you can defend, measured by booked appointments rather than marketing reports.